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ABSTRACT
The incidence rate of schizencephaly is 1.5 in 100,000 live births and the rate of
holoprosencephaly is 1 in 16,000 live births. Both malformations are rare, but our
institution has seen a dramatic increase in both malformations in recent years
with no known cause. Schizencephaly is the most severe cortical malformation
and holoprosencephaly is the most common defect in the prosencephalon during
development. However, it is still not very common to see a fetus with this defect live
to delivery. Our institution, a regional hospital in central Appalachia, has seen four
cases of schizencephaly and three cases of holoprosencephaly within two years. No
two neonates seem to share a common factor. All had different co-morbidities and
presentations, all mothers were of different ages and showed few risk factors if any for
these deformities. This paper is a report of the cases found of these rare birth defects
seen at our institution in recent years.
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INTRODUCTION
Our institution, a regional hospital in central
Appalachia, has seen an unusual increase in brain
abnormalities over the past ten years with no
obvious cause, with a cluster of severe congenital
brain malformations in the last thirty months.
These malformations include schizencephaly
and holoprosencephaly. Schizencephaly is the
most severe form of a cortical malformation.1
Schizencephaly is estimated to affect 1.5 out of
100,000 live births. The clefting of the cerebral
mantle most commonly occurs in the frontal
lobes but can occur in the parietal lobe as well.2
Schizencephaly symptoms include developmental
delays, speech and language difficulties, brainspinal cord communication problems, microcephaly,
hydrocephalus, seizures, complete or partial paralysis,
and abnormal muscle tone. The severity of the
persons’ symptoms depends on cleft severity and
the presence of other brain abnormalities.3 There is
no known cause of schizencephaly, but it has been
linked to genes EMX2, SIX3, SHH, and COL4A1. There
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are also non-genetic links such as maternal age under
twenty-four years old, infections during gestation
specifically cytomegalovirus infection (CMV), folate
deficiency, and exposure to medication during
development that can interrupt blood flow before
birth.4,5 There is no cure for this malformation. There
is still little known about schizencephaly and more
research needs to be done in this area.
Holoprosencephaly (HPE) is the most common
malformation of the prosencephalon, occurring
in 1 in 250 embryos and 1 in 16,000 live births.6
This defect will occur within the first four weeks of
embryogenesis; it is said to be as specific as between
the 18th and 28th day after conception. HPE affects
3-4% of all live births.7,8 HPE is a nonseparation of
the deep grey nuclei, and this is used to diagnose
a spectrum of disorders with the same etiology. Of
this spectrum of disorders, the diagnoses are graded
on the degree of non-separation of the nuclei.
The severity of the craniofacial malformations is
dependent on the degree of nonseparation of the
grey nuclei. With HPE cases it has been said that “the
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face follows the brain” meaning the severity of the
malformation will correlate to the separation or lack
thereof within the brain.6,9,10 The risk factors for a fetus
developing HPE can include a maternal obstetrical
history of a previous spontaneous abortion, first
trimester bleeding during the pregnancy in question
or previous pregnancies, and/or chromosomal
abnormalities. Several of the recognized maternal
risk factors are diabetes mellitus gestational or
chronic, alcoholism, smoking, prenatal exposure
to retinoic acid, cholesterol biosynthetic inhibitors,
infections, and hypothyroidism.10 Other possible risk
factors include the use of contraceptives, before or
early during the pregnancy, the use of salicylates,
hypocholesterolemia, low-calorie diets, and
cholesterol synthesis via the Sonic hedgehog (SHH)
pathway.11
The population our institution serves has had
numerous high-risk factors for these brain
malformations for years with the highest rate
nationally for diabetes12, smoking during
pregnancy12,13, and heart disease.13 Considering
all of the risk factors and the prevalence of these
decreasing within this population over the past
few years, it is unclear what could have caused a
seemingly random spike in the rates of these very
specific birth defects or why these are the first
our institution has seen. When based on the rates
of teratogens from previous years present in this
population, we should have been seeing them all
along. This study aims to discuss this cluster of rare
brain anomalies that were seen in a close time frame
and proximity to our institution.
CASE PRESENTATION
The finding of a single case of HPE is rare; the rate
of HPE in live births is 1 in 16,000 newborns. Within
two years our institution diagnosed four cases of
schizencephaly. Also, during these two years, in
less than seven months, our institution saw and
diagnosed three cases of HPE, two males and one set
of female twins; only one of the twins was formally
diagnosed with HPE. There are no shared risk factors
or genetic abnormalities among the presented
cases. These neonates have no obvious cause of this
malformation, and they all have very little if anything
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in common. The information about each of these
neonates at birth and during pregnancy can be
found in Table 1 under each case number for easy
comparison.
METHODS
A retrospective analysis was completed to further
examine the incidence of these two rare central
nervous system malformations seen from 2017 until
2019. The schizencephaly cases are diagnosed by
the degree of clefting seen in the cerebral mantle of
the various lobes of the brain. Holoprosencephaly
was confirmed by a lack of separation of the two
hemispheres of the brain. All seven neonates’
diagnoses were confirmed radiographically.
RESULTS
In the ten years from January first to the end
of December 2019, seven neonates were born
weighing 800 grams or greater and were
diagnosed by the treating physicians as small for
gestational age.14 Of these seven neonates, three
were diagnosed with holoprosencephaly and the
remaining four were diagnosed with schizencephaly.
The details of these neonates can be seen in Table 1.
DISCUSSION
The population in West Virginia has significant
co-morbidities and lifestyle choices that all align
with the literature for potential risk factors of brain
malformation. Despite the high number of risk
factors, no congenital brain malformations had been
identified at our institution since the installation
of our electronic medical record in 2008, with no
memory of additional cases from long-time staff.
We have described the geographic cluster of rare
and debilitating encephalopathies. With no previous
cases recorded or in memory of the staff, and as
rare as these malformations are embryologically,
seven cases in just over two years is statistically
improbable.
The children with schizencephaly (chronologically
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TABLE 1: This table compares the details of each case including the gestational age, weight, head circumference,
APGAR scores, exposure to maternal medicines and substances and other details of the gestations and maternal
history. The results of any genetic testing are also listed in the table above. All cases were determined by the treating
physician to be small for gestational age (SGA).
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- 1, 4, 6, and 7) do not appear to have any common
risk factors. The first had no risk factors that have
been described in the literature. However, the
mother did use multiple illicit substances (including
opioids, amphetamines, and marijuana) of unknown
quantities throughout her pregnancy. We can only
speculate if this was a contributing factor to the
malformation in this neonate. The fourth neonate’s
mother was 22 years old which is considered a
risk factor for schizencephaly and upon genetic
testing, it was found that the neonate had a gene
duplication that was not thought to contribute to
the brain malformation; the mother had no other
risk factors described in the literature. The sixth
neonate’s mother was 18 years old and she had a
previous spontaneous abortion; no genetic testing
was performed for this child and so a contributing
genetic variant cannot be identified as the cause
but no other risk factors were found in the mother’s
history. The last child seen with schizencephaly had
a confirmed CMV infection during gestation as the
only confirmed risk factor.
The children with holoprosencephaly
(chronologically - 2, 3, and 5), like the
schizencephaly, have little identified commonalities.
The second child had no abnormalities on genetic
testing. The mother did admit to smoking cigarettes
during her pregnancy with no other risk factors.
The third child no known genetic abnormalities,
no previous spontaneous abortion (SAB), no first
trimester bleeding, no reported diabetes mellitus,
no reported alcohol consumption, or tobacco
usage during the pregnancy. This neonate was
the only child that has no identified risk factors for
this malformation. Whereas the fifth neonate had
the most risk factors of all seven, this mother had
many issues with her previous pregnancies, and the
pregnancy discussed in this paper was complicated
with multiple fetuses and polyhydramnios. The
mother also admitted to smoking cigarettes and
using alcohol during her pregnancy. Lemonie
reported in a paper from 1968 that on the more
severe end of the fetal alcohol spectrum there were
malformations of the brain some of which include
semi-lobar holoprosencephaly and agenesis or
absence of the corpus callosum.15
The first, third, and fourth neonates received genetic
testing by microarray-based Comparative Genomic
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Hybridization (CGH); the first and third neonates
were negative and the fourth was considered to
have a minor duplication of no consequence to this
malformation. In all seven cases, the umbilical cords
were normal and unremarkable, except for the sixth
whose cord was dried, and abnormalities could not
be detected.
There was one common factor across the neonates
in this series: all seven children discussed here were
small for gestational age, which is unusual in this
population. Fetal insulin is the hormonal regulator
for fetal growth during gestation, the amount of
insulin is dependent on the amount of glucose the
fetus attains from the mother’s blood.16,17 The
maternal BMI can be seen in Table 1. BMI has been
correlated to insulin secretion and sensitivity.18,19
Fetal insulin secretion is the primary regulator for
growth during development, if the mother had an
increased glycemic index it would be more likely
for their child to be appropriate or large for their
gestational age. However, in the seven children, we
have seen with these malformations only two of the
mothers (the fourth and fifth) were overweight and
both neonates were still small for their gestational
age. The mothers of the third, sixth, and seventh all
had BMIs in the normal range and the children were
also small for gestational age. The first and second
mothers’ information on their BMIs could not be
found.
It is likely we will not find the definitive cause of
these malformations. More research needs to be
done into the causes of the malformations and the
rural Appalachian population. It is not clear what
may have caused this crop of encephalopathies
in such a short time or if this is not an arbitrary
occurrence and this is the new normal for our
population. We need more research into the causes
and the treatments of these malformations to best
serve our community.
Within the last ten years, two other clusters of birth
defects have been seen at our institution. The two
clusters that have been seen were five cases of
myelomeningocele within two years and six cases
of imperforated anus over ten years; however, four
of these cases were within two years. Due to the
proximity geographically of these cases to one
another, environmental teratogenic exposure has
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GRAPH 1: This graph is a timeline of brain malformations seen at our institution from 2009 to 2019.

been hypothesized and should be explored for a
more complete investigation as to the potential
causes of these malformations.
CONCLUSION
Our institution has witnessed a recent and
unprecedented increase in infants diagnosed with
schizencephaly and holoprosencephaly with no
known cause. A timeline with these cases can be
seen in Graph 1. The population we serve exhibits
a great many risk factors and co-morbidities and
has for years. However, we are only now seeing the
presentation of this malformation and other birth
abnormalities with no obvious cause. Without more
information about the pregnancies and exposures,
we can only speculate as to the causes. To find such
a cause and/or more risk factors that can lead to the
development of this encephalopathy, more research
and investigation needs to be done.

MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

AUTHOR AFFILIATIONS
1. Marshall University Joan C. Edwards School of
Medicine, Huntington, West Virginia
2. Hoops Family Children’s Hospital at Cabell
Huntington Hospital, Huntington, West Virginia
3. Vanderbilt University Medical Center, Nashville,
Tennessee
REFERENCES
1. Volpe J, Inder T, Darras B, de Vries L, du Plessis
A, Neil J, Perlman J..Volpe’s Neurology of the
Newborn. 6th ed: Elsevier; 2017.
2. Stopa J, Kucharska-Miąsik I, Dziurzyńska-Białek
E, et al. Diagnostic imaging and problems of
schizencephaly. Pol J Radiol 2014;79:444-9.
3. Schizencepephaly: Genetic and Rare Diseases
Information Center. National Center for
Advancing Translational Sciences. (Accessed 19
Feb 2020, at https://rarediseases.info.nih.gov/

mds.marshall.edu/mjm
© 2021 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 6 Issue 4

diseases/166/schizencephaly.)
4. Howe DT, Rankin J, Draper ES. Schizencephaly
prevalence, prenatal diagnosis and clues to
etiology: a register-based study. Ultrasound in
Obstetrics & Gynecology 2012;39:75-82.
5. We are Rare: Schizencephaly. We Are R.A.R.E.
(Accessed 19 Feb 2020, at http://wearerare.org/
schizencephaly/.)
6. Holoprosencephaly: Genetic and Rare Diseases
Information Center. National Center for
Advancing Translational Sciences. (Accessed 19
Feb 2020, at https://rarediseases.info.nih.gov/
diseases/6665/holoprosencephaly/cases/27877.)
7. Stashinko EE, Clegg NJ, Kammann HA, et al. A
retrospective survey of perinatal risk factors of
104 living children with holoprosencephaly. Am J
Med Genet A 2004;128A:114-9.
8. Levey EB, Stashinko E, Clegg NJ, Delgado
MR. Management of children with
holoprosencephaly. Am J Med Genet C Semin
Med Genet 2010;154C:183-90.
9. Kauvar EF, Muenke M. Holoprosencephaly:
recommendations for diagnosis and
management. Curr Opin Pediatr 2010;22:687-95.
10. Dubourg C, Bendavid C, Pasquier L, Henry C,
Odent S, David V. Holoprosencephaly. Orphanet J
Rare Dis 2007;2:8.
11. Woollett LA. Review: Transport of maternal
cholesterol to the fetal circulation. Placenta
2011;32 Suppl 2:S218-S21.
12. WV Department of Health and Human Resources
HSC. West Virginia Behavioral Risk Factor
Surveillance System Report, 20162018.
13. America’s Health Rankings analysis of
CDC WONDER Online Database, Natality
public-use data. United Health Foundation.
(Accessed 19 Feb 2020, at https://www.
americashealthrankings.org/explore/healthof-women-and-children/measure/Smoking_
pregnancy/state/WV.)
14. Kiserud T, Piaggio G, Carroli G, et al. The World
Health Organization Fetal Growth Charts: A
Multinational Longitudinal Study of Ultrasound
Biometric Measurements and Estimated Fetal
Weight. PLoS Med 2017;14:e1002220.
15. Lemoine P, Harousseau H, Borteyru JP, Menuet
JC. Children of alcoholic parents--observed
anomalies: discussion of 127 cases. Ther Drug
Monit 1968;25:132-6.
16. Fowden AL. The role of insulin in fetal growth.
MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

Early Hum Dev 1992;29:177-81.
17. Fowden AL. Insulin deficiency: effects on fetal
growth and development. J Paediatr Child Health
1993;29:6-11.
18. Anstey KJ, Christensen H, Butterworth P, et al.
Cohort profile: the PATH through life project. Int J
Epidemiol 2012;41:951-60.
19. Walsh EI, Shaw J, Cherbuin N. Trajectories of BMI
change impact glucose and insulin metabolism.
Nutr Metab Cardiovasc Dis 2018;28:243-51.

mds.marshall.edu/mjm
© 2021 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 6 Issue 4

